Methylation

A process whereby a molecule CH3, is added to DNA, RNA or a protein.

When it affects DNA, a CH3 group or a methyl group is added to a cytosine when it is followed by the guanosine.

In DNA it can be associated with absent gene transcription, which may becomes a stable state that is physiologically irreversible.

Methylation is a vital biochemical process where a methyl group (CH_{3} is added to DNA, proteins, or other molecules, acting as a switch that regulates gene expression, protein function, and cellular detoxification.

DNA methylation is a covalent epigenetic modification in which a methyl group is added to the C5 position of cytosine, almost exclusively at CpG dinucleotides, and serves as a fundamental mechanism for regulating gene expression without altering the DNA sequence itself.

It is essential for turning genes on or off, controlling neurotransmitters, and supporting long-term health.

Poor methylation can lead to fatigue, anxiety, and chronic disease.

Methylation involves transferring a methyl group to a target molecule, often using adenosylmethionine (SAMe) as the methyl donor.DNA.

Methylation: This occurs when a methyl group attaches to DNA (often at CpG sites), turning genes off or on and allowing cells to differentiate into specific tissues.

DNA methylation is governed by three functional classes of enzymes:

Writers (DNMTs): DNMT3A and DNMT3B establish new methylation patterns, while DNMT1 (with UHRF1) copies existing methylation to daughter strands during DNA replication.

Erasers (TETs): TET1, TET2, and TET3 oxidize 5-methylcytosine (5mC) to intermediates (5hmC, 5fC, 5caC), leading to active demethylation.

Passive demethylation also occurs during replication when DNMT1 activity is absent.

Readers: Proteins such as MeCP2 recognize methylated DNA and recruit chromatin-remodeling factors that generate a closed, transcriptionally repressive chromatin state.

The methylation process depends heavily on nutrients like folate (B9), vitamin B12, and B6 to produce SAMe.

Methylation regulates which genes are active without changing the DNA sequence.

It is crucial for producing neurotransmitters like serotonin and dopamine, impacting mood.

Detoxification: Assists the liver in processing and eliminating toxins.

Energy Production: Involved in creating energy in cells.

Immune Function: Helps regulate immune responses.

Poor methylation is linked to serious health conditions, including cancer due to silenced protective genes, heart disease, and mental health challenges.

Symptoms of Poor Methylation:Persistent Fatigue/Burnout: Chronic lack of energy.

Mental Health Issues: Anxiety, low mood, depression, and irritability.

Cognitive Issues: Brain fog or difficulty concentrating.

Hormonal Imbalances: PMS and estrogen dominance.

Poor recovery from stress/exercise, sensitivities to alcohol or food, and insomnia.

Supporting Methylation: Lifestyle choices, such as eating folate-rich foods, reducing alcohol consumption, and quitting smoking, can improve methylation patterns.

Biological Functions

Methylation at gene promoters and enhancers generally represses transcription, while gene body methylation is associated with active transcription.

Key physiological roles include:

Tissue-specific gene regulation of each cell type has a unique methylation pattern that maintains cellular identity.

Genomic imprinting

X-chromosome inactivation

Transposable element silencing maintaining genomic stability

Embryonic development-dynamic waves of demethylation and re-methylation occur during early development

Aberrant DNA methylation is a hallmark of disease, particularly cancer, where genome-wide hypomethylation that leads to genomic instability and oncogene activation coexists with focal promoter hypermethylation silencing tumor suppressor genes.

Similar patterns of global hypomethylation with localized hypermethylation are observed in aging.

DNA methylation changes have also been implicated in neuropsychiatric disorders, cardiovascular disease, and other complex conditions.

Because methylation is chemically stable, and a valuable clinical biomarker for early cancer detection, tumor classification, and treatment response monitoring.

Therapeutically, DNA methyltransferase inhibitors (e.g., azacitidine, decitabine) are used in hematologic malignancies to reverse aberrant hypermethylation.